| North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I … A Alikhan, C Sayed, A Alavi, R Alhusayen, A Brassard, C Burkhart, ... Journal of the American Academy of Dermatology 81 (1), 76-90, 2019 | 628 | 2019 |
| Chemotherapeutic agents and the skin: an update N Heidary, H Naik, S Burgin Journal of the American Academy of Dermatology 58 (4), 545-570, 2008 | 312 | 2008 |
| Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project A Garg, E Neuren, D Cha, JS Kirby, JR Ingram, GBE Jemec, S Esmann, ... Journal of the American Academy of Dermatology 82 (2), 366-376, 2020 | 248 | 2020 |
| Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective observational study HB Naik, B Natarajan, E Stansky, MA Ahlman, H Teague, T Salahuddin, ... Arteriosclerosis, thrombosis, and vascular biology 35 (12), 2667-2676, 2015 | 201 | 2015 |
| Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations A Garg, N Malviya, A Strunk, S Wright, A Alavi, R Alhusayen, A Alikhan, ... Journal of the American Academy of Dermatology 86 (5), 1092-1101, 2022 | 195 | 2022 |
| Autoinflammatory pustular neutrophilic diseases HB Naik, EW Cowen Dermatologic clinics 31 (3), 405-425, 2013 | 154 | 2013 |
| Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31 SK Horrigan, ZH Arbieva, HY Xie, J Kravarusic, NC Fulton, H Naik, TT Le, ... Blood, The Journal of the American Society of Hematology 95 (7), 2372-2377, 2000 | 144 | 2000 |
| Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy MM Lowe, HB Naik, S Clancy, M Pauli, KM Smith, Y Bi, R Dunstan, ... JCI insight 5 (19), e139932, 2020 | 119 | 2020 |
| Oral disease profiles in chronic graft versus host disease CW Bassim, H Fassil, JW Mays, D Edwards, K Baird, SM Steinberg, ... Journal of dental research 94 (4), 547-554, 2015 | 77 | 2015 |
| Skin microbiota perturbations are distinct and disease severity–dependent in hidradenitis suppurativa HB Naik, JH Jo, M Paul, HH Kong Journal of Investigative Dermatology 140 (4), 922-925. e3, 2020 | 73 | 2020 |
| Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients C Liy-Wong, M Kim, AY Kirkorian, LF Eichenfield, LZ Diaz, A Horev, ... JAMA dermatology 157 (4), 385-391, 2021 | 61 | 2021 |
| Distribution of self-reported hidradenitis suppurativa age at onset HB Naik, M Paul, SR Cohen, A Alavi, M Suàrez-Fariñas, MA Lowes JAMA dermatology 155 (8), 971-973, 2019 | 55 | 2019 |
| Upregulation of IFN-inducible and damage-response pathways in chronic graft-versus-host disease FT Hakim, S Memon, P Jin, MM Imanguli, H Wang, N Rehman, XY Yan, ... The Journal of Immunology 197 (9), 3490-3503, 2016 | 53 | 2016 |
| Clinical significance of autoantibodies in a large cohort of patients with chronic graft‐versus‐host disease defined by NIH criteria Z Kuzmina, V Gounden, L Curtis, D Avila, TT Rnp, J Baruffaldi, EW Cowen, ... American journal of hematology 90 (2), 114-119, 2015 | 51 | 2015 |
| Identification of biomarkers and critical evaluation of biomarker validation in hidradenitis suppurativa: a systematic review S Der Sarkissian, S Hessam, JS Kirby, MA Lowes, D Mintoff, HB Naik, ... JAMA dermatology 158 (3), 300-313, 2022 | 47 | 2022 |
| The TNFRSF members CD27 and OX40 coordinately limit TH17 differentiation in regulatory T cells KA Remedios, B Zirak, PM Sandoval, MM Lowe, D Boda, E Henley, ... Science immunology 3 (30), eaau2042, 2018 | 45 | 2018 |
| Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline … S Rose, J Dave, C Millo, HB Naik, EL Siegel, NN Mehta Arthritis Research & Therapy 16, 1-9, 2014 | 45 | 2014 |
| Identifying barriers to care and research in hidradenitis suppurativa: findings from a patient engagement event N Shukla, M Paul, M Halley, MA Lowes, V Hester, C Aguilar, S Guilbault, ... British Journal of Dermatology 182 (6), 1490-1492, 2020 | 38 | 2020 |
| Are bacteria infectious pathogens in hidradenitis suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017 HB Naik, A Nassif, MS Ramesh, G Schultz, V Piguet, A Alavi, MA Lowes Journal of Investigative Dermatology 139 (1), 13-16, 2019 | 37 | 2019 |
| Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies JW Frew, K Navrazhina, AS Byrd, A Garg, JR Ingram, JS Kirby, MA Lowes, ... British Journal of Dermatology 181 (6), 1339-1341, 2019 | 36 | 2019 |
